|
|
Volumn 9, Issue 6, 2010, Pages 564-565
|
|
PML: underdiagnosed in MS patients on natalizumab - Authors' reply
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
GLATIRAMER;
INTERFERON;
NATALIZUMAB;
IMMUNOLOGIC FACTOR;
MONOCLONAL ANTIBODY;
CEREBROSPINAL FLUID ANALYSIS;
DIAGNOSTIC PROCEDURE;
DISEASE EXACERBATION;
DISEASE SURVEILLANCE;
DRUG WITHDRAWAL;
EUROPE;
HUMAN;
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME;
JC VIRUS;
LETTER;
MEDICAL SPECIALIST;
MULTIPLE SCLEROSIS;
NEUROLOGIC EXAMINATION;
NUCLEAR MAGNETIC RESONANCE IMAGING;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
RELAPSE;
RISK ASSESSMENT;
RISK MANAGEMENT;
TREATMENT OUTCOME;
UNITED STATES;
VIRUS LOAD;
DISEASE COURSE;
EARLY DIAGNOSIS;
INCIDENCE;
LITERATURE;
NOTE;
ANTIBODIES, MONOCLONAL;
DISEASE PROGRESSION;
EARLY DIAGNOSIS;
EUROPE;
HUMANS;
IMMUNOLOGIC FACTORS;
INCIDENCE;
LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL;
MULTIPLE SCLEROSIS;
REVIEW LITERATURE AS TOPIC;
UNITED STATES;
|
|
EID: 77952317235
PISSN: 14744422
EISSN: None
Source Type: Journal
DOI: 10.1016/S1474-4422(10)70123-X Document Type: Letter |
|
Times cited : (2)
|
|
References (1)
|
